[
  {
    "ts": null,
    "headline": "Macquarie Value Fund Q2 2025 Commentary",
    "summary": "For the second quarter, Macquarie Value Fund Institutional Class shares trailed its benchmark, the Russell 1000Â® Value Index. Read more here.",
    "url": "https://finnhub.io/api/news?id=7f029f701046186913fcd04ac3c08f98450200c79587e25d76e190c6fd16d965",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755474300,
      "headline": "Macquarie Value Fund Q2 2025 Commentary",
      "id": 136404933,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2178335816/image_2178335816.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "For the second quarter, Macquarie Value Fund Institutional Class shares trailed its benchmark, the Russell 1000Â® Value Index. Read more here.",
      "url": "https://finnhub.io/api/news?id=7f029f701046186913fcd04ac3c08f98450200c79587e25d76e190c6fd16d965"
    }
  },
  {
    "ts": null,
    "headline": "OPKO Health (OPK) Advances EBV Vaccine and GLP-1 Pipeline While Streamlining Diagnostics",
    "summary": "We recently published 12 Best Healthcare Stocks to Buy Under $30. OPKO Health, Inc. (NASDAQ:OPK) is one of the best healthcare stocks. OPKO Health, Inc. (NASDAQ:OPK) is a diversified healthcare company with operations in diagnostics, pharmaceuticals, and innovative therapies, anchored by BioReference Laboratories and an expanding drug development pipeline. The company is advancing programs in […]",
    "url": "https://finnhub.io/api/news?id=c0a21d9b39f1e7ec1e65854d0fdc18c45a197eab8aba3d4dbd67599fdb076f73",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755469438,
      "headline": "OPKO Health (OPK) Advances EBV Vaccine and GLP-1 Pipeline While Streamlining Diagnostics",
      "id": 136408500,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "We recently published 12 Best Healthcare Stocks to Buy Under $30. OPKO Health, Inc. (NASDAQ:OPK) is one of the best healthcare stocks. OPKO Health, Inc. (NASDAQ:OPK) is a diversified healthcare company with operations in diagnostics, pharmaceuticals, and innovative therapies, anchored by BioReference Laboratories and an expanding drug development pipeline. The company is advancing programs in […]",
      "url": "https://finnhub.io/api/news?id=c0a21d9b39f1e7ec1e65854d0fdc18c45a197eab8aba3d4dbd67599fdb076f73"
    }
  },
  {
    "ts": null,
    "headline": "Merck & Co., Inc. (MRK) Announces Update on Phase 3 KEYNOTE-905 Trial",
    "summary": "Merck & Co., Inc. (NYSE:MRK) is included in our list of the 10 Most Undervalued Value Stocks to Buy Now. On August 12, 2025, Merck & Co., Inc. (NYSE:MRK) announced an update regarding its Phase 3 KEYNOTE-905 trial. According to the update, the trial met its primary and key secondary endpoints in patients with muscle-invasive […]",
    "url": "https://finnhub.io/api/news?id=a48e5e746aeace32d093c50284cdc32e4b2b07862cb94bbcff2c5a43a31fe6f0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755412241,
      "headline": "Merck & Co., Inc. (MRK) Announces Update on Phase 3 KEYNOTE-905 Trial",
      "id": 136408501,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Merck & Co., Inc. (NYSE:MRK) is included in our list of the 10 Most Undervalued Value Stocks to Buy Now. On August 12, 2025, Merck & Co., Inc. (NYSE:MRK) announced an update regarding its Phase 3 KEYNOTE-905 trial. According to the update, the trial met its primary and key secondary endpoints in patients with muscle-invasive […]",
      "url": "https://finnhub.io/api/news?id=a48e5e746aeace32d093c50284cdc32e4b2b07862cb94bbcff2c5a43a31fe6f0"
    }
  }
]